Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 121

1.

The role of interleukin-2, all-trans retinoic acid, and natural killer cells: surveillance mechanisms in anti-GD2 antibody therapy in neuroblastoma.

Nguyen R, Houston J, Chan WK, Finkelstein D, Dyer MA.

Cancer Immunol Immunother. 2018 Jan 11. doi: 10.1007/s00262-017-2108-6. [Epub ahead of print]

PMID:
29327110
2.

Orthotopic patient-derived xenografts of paediatric solid tumours.

Stewart E, Federico SM, Chen X, Shelat AA, Bradley C, Gordon B, Karlstrom A, Twarog NR, Clay MR, Bahrami A, Freeman BB 3rd, Xu B, Zhou X, Wu J, Honnell V, Ocarz M, Blankenship K, Dapper J, Mardis ER, Wilson RK, Downing J, Zhang J, Easton J, Pappo A, Dyer MA.

Nature. 2017 Sep 7;549(7670):96-100. doi: 10.1038/nature23647. Epub 2017 Aug 30.

PMID:
28854174
3.

The Dynamic Epigenetic Landscape of the Retina During Development, Reprogramming, and Tumorigenesis.

Aldiri I, Xu B, Wang L, Chen X, Hiler D, Griffiths L, Valentine M, Shirinifard A, Thiagarajan S, Sablauer A, Barabas ME, Zhang J, Johnson D, Frase S, Zhou X, Easton J, Zhang J, Mardis ER, Wilson RK, Downing JR, Dyer MA; St. Jude Children’s Research Hospital—Washington University Pediatric Cancer Genome Project.

Neuron. 2017 May 3;94(3):550-568.e10. doi: 10.1016/j.neuron.2017.04.022.

PMID:
28472656
4.

Performance of a docking/molecular dynamics protocol for virtual screening of nutlin-class inhibitors of Mdmx.

Bharatham N, Finch KE, Min J, Mayasundari A, Dyer MA, Guy RK, Bashford D.

J Mol Graph Model. 2017 Jun;74:54-60. doi: 10.1016/j.jmgm.2017.02.014. Epub 2017 Feb 24.

PMID:
28351017
5.

ATRX and DAXX: Mechanisms and Mutations.

Dyer MA, Qadeer ZA, Valle-Garcia D, Bernstein E.

Cold Spring Harb Perspect Med. 2017 Mar 1;7(3). pii: a026567. doi: 10.1101/cshperspect.a026567. Review.

PMID:
28062559
6.

Biomedicine: An eye on retinal recovery.

Dyer MA.

Nature. 2016 Dec 15;540(7633):350-351. doi: 10.1038/nature20487. Epub 2016 Nov 30. No abstract available.

PMID:
27919071
7.

Reprogramming of mouse retinal neurons and standardized quantification of their differentiation in 3D retinal cultures.

Hiler DJ, Barabas ME, Griffiths LM, Dyer MA.

Nat Protoc. 2016 Oct;11(10):1955-1976. doi: 10.1038/nprot.2016.109. Epub 2016 Sep 15.

8.

Lessons from Retinoblastoma: Implications for Cancer, Development, Evolution, and Regenerative Medicine.

Dyer MA.

Trends Mol Med. 2016 Oct;22(10):863-876. doi: 10.1016/j.molmed.2016.07.010. Epub 2016 Aug 23. Review.

9.

Stem Cells Expand Insights into Human Brain Evolution.

Dyer MA.

Cell Stem Cell. 2016 Apr 7;18(4):425-6. doi: 10.1016/j.stem.2016.03.017.

10.

ATRX binds to atypical chromatin domains at the 3' exons of zinc finger genes to preserve H3K9me3 enrichment.

Valle-García D, Qadeer ZA, McHugh DS, Ghiraldini FG, Chowdhury AH, Hasson D, Dyer MA, Recillas-Targa F, Bernstein E.

Epigenetics. 2016 Jun 2;11(6):398-414. doi: 10.1080/15592294.2016.1169351. Epub 2016 Mar 30.

11.

Monitoring Ligand-Induced Protein Ordering in Drug Discovery.

Grace CR, Ban D, Min J, Mayasundari A, Min L, Finch KE, Griffiths L, Bharatham N, Bashford D, Kiplin Guy R, Dyer MA, Kriwacki RW.

J Mol Biol. 2016 Mar 27;428(6):1290-1303. doi: 10.1016/j.jmb.2016.01.016. Epub 2016 Jan 23.

12.

Ipilmumab and cranial radiation in metastatic melanoma patients: a case series and review.

Schoenfeld JD, Mahadevan A, Floyd SR, Dyer MA, Catalano PJ, Alexander BM, McDermott DF, Kaplan ID.

J Immunother Cancer. 2015 Dec 15;3:50. doi: 10.1186/s40425-015-0095-8. eCollection 2015.

13.

Brg1 coordinates multiple processes during retinogenesis and is a tumor suppressor in retinoblastoma.

Aldiri I, Ajioka I, Xu B, Zhang J, Chen X, Benavente C, Finkelstein D, Johnson D, Akiyama J, Pennacchio LA, Dyer MA.

Development. 2015 Dec 1;142(23):4092-106. doi: 10.1242/dev.124800.

14.

Preclinical Models Provide Scientific Justification and Translational Relevance for Moving Novel Therapeutics into Clinical Trials for Pediatric Cancer.

Langenau DM, Sweet-Cordero A, Wechsler-Reya R, Dyer MA.

Cancer Res. 2015 Dec 15;75(24):5176-5186. doi: 10.1158/0008-5472.CAN-15-1308. Epub 2015 Dec 1. Review.

15.

TNF Counterbalances the Emergence of M2 Tumor Macrophages.

Kratochvill F, Neale G, Haverkamp JM, Van de Velde LA, Smith AM, Kawauchi D, McEvoy J, Roussel MF, Dyer MA, Qualls JE, Murray PJ.

Cell Rep. 2015 Sep 22;12(11):1902-14. doi: 10.1016/j.celrep.2015.08.033. Epub 2015 Sep 10.

16.

Genetic and Epigenetic Discoveries in Human Retinoblastoma.

McEvoy JD, Dyer MA.

Crit Rev Oncog. 2015;20(3-4):217-25. Review.

17.

Progress in Small Molecule Therapeutics for the Treatment of Retinoblastoma.

Pritchard EM, Dyer MA, Guy RK.

Mini Rev Med Chem. 2016;16(6):430-54. Review.

18.

Quantification of Retinogenesis in 3D Cultures Reveals Epigenetic Memory and Higher Efficiency in iPSCs Derived from Rod Photoreceptors.

Hiler D, Chen X, Hazen J, Kupriyanov S, Carroll PA, Qu C, Xu B, Johnson D, Griffiths L, Frase S, Rodriguez AR, Martin G, Zhang J, Jeon J, Fan Y, Finkelstein D, Eisenman RN, Baldwin K, Dyer MA.

Cell Stem Cell. 2015 Jul 2;17(1):101-15. doi: 10.1016/j.stem.2015.05.015.

19.

The Childhood Solid Tumor Network: A new resource for the developmental biology and oncology research communities.

Stewart E, Federico S, Karlstrom A, Shelat A, Sablauer A, Pappo A, Dyer MA.

Dev Biol. 2016 Mar 15;411(2):287-293. doi: 10.1016/j.ydbio.2015.03.001. Epub 2015 Jun 9.

20.

A Sleeping Beauty forward genetic screen identifies new genes and pathways driving osteosarcoma development and metastasis.

Moriarity BS, Otto GM, Rahrmann EP, Rathe SK, Wolf NK, Weg MT, Manlove LA, LaRue RS, Temiz NA, Molyneux SD, Choi K, Holly KJ, Sarver AL, Scott MC, Forster CL, Modiano JF, Khanna C, Hewitt SM, Khokha R, Yang Y, Gorlick R, Dyer MA, Largaespada DA.

Nat Genet. 2015 Jun;47(6):615-24. doi: 10.1038/ng.3293. Epub 2015 May 11.

Supplemental Content

Support Center